Occurrence Of Long COVID In Healthcare Workers At A University Hospital And Challenges In Insurance And Compensation Evaluation.

Q2 Medicine
C Giorgianni, V Cianci, C Pitrone, G Burrascano, C Mondello, N Gullì, P Gualniera, A Asmundo, D Sapienza
{"title":"Occurrence Of Long COVID In Healthcare Workers At A University Hospital And Challenges In Insurance And Compensation Evaluation.","authors":"C Giorgianni, V Cianci, C Pitrone, G Burrascano, C Mondello, N Gullì, P Gualniera, A Asmundo, D Sapienza","doi":"10.7417/CT.2025.5208","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developed in 2019, led to the outbreak of the COVID-19 pandemic state, which have significantly impacted on healthcare systems worldwide. During the pandemic state, in addition to all the problems related to high mortality and morbidity during the active phase of the disease, it had to deal with a condition known as \"Long-COVID\". Long-COVID includes both persistent symptomatic forms, where signs and symptoms last between 4 and 12 weeks, and post-COVID syndrome, where symptoms persist beyond 12 weeks. The evaluation system categorizes COVID-19 outcomes into four classes based on the degree of biological validity impairment: mild, moderate, moderate-severe, and severe. In the insurance field, this new \"entity\" led to difficulties related to damages compensation for infections developed in workplace, which has not completely been clarified nor today.</p><p><strong>Methods: </strong>The study was conducted on a sample of 3,127 health-care workers employed at the \"G. Martino\" University Hospital, in Messina. The percentage of individuals who contracted COVID-19 was analysed, evaluating how many were infected at workplace. Among those who contracted the virus at work, we further examined how many healthcare professionals were eligible for compensation under insurance frameworks related to Long- COVID.</p><p><strong>Results: </strong>The data analysis reveals that, out of the entire sample examined, 10 healthcare workers developed Long-COVID syndrome, with a severity classified as moderate (Biological Damage according to social insurance of healthcare workers: 1-15%). The lingering ef-fects included persistent asthenia, anosmia, stress-induced dyspnoea, outcomes of instrumentally documented pneumonia and myocarditis, as well as neuromuscular disorders. The collected data confirms that healthcare professionals had the highest percentage of COVID-19 infections (Fig. 1), with an infection rate of 23%, more than half of which occurred in the workplace.</p><p><strong>Discussion and conclusions: </strong>The definition of long-COVID is still quite complicated, as the ever-increasing number of symptoms that are attributable to this pathology, and the variability in the times of its onset, make its nosographic framework extremely difficult. In addition to the clinical-scientific difficulties arising from this condition, the impossibility of adequately classifying the pathology is associated with an equally complex management of the costs that the State must bear to restore the damage, as it usually happens in case of sequelae of infections contracted at workplace.</p>","PeriodicalId":50686,"journal":{"name":"Clinica Terapeutica","volume":"176 2","pages":"213-218"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Terapeutica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7417/CT.2025.5208","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developed in 2019, led to the outbreak of the COVID-19 pandemic state, which have significantly impacted on healthcare systems worldwide. During the pandemic state, in addition to all the problems related to high mortality and morbidity during the active phase of the disease, it had to deal with a condition known as "Long-COVID". Long-COVID includes both persistent symptomatic forms, where signs and symptoms last between 4 and 12 weeks, and post-COVID syndrome, where symptoms persist beyond 12 weeks. The evaluation system categorizes COVID-19 outcomes into four classes based on the degree of biological validity impairment: mild, moderate, moderate-severe, and severe. In the insurance field, this new "entity" led to difficulties related to damages compensation for infections developed in workplace, which has not completely been clarified nor today.

Methods: The study was conducted on a sample of 3,127 health-care workers employed at the "G. Martino" University Hospital, in Messina. The percentage of individuals who contracted COVID-19 was analysed, evaluating how many were infected at workplace. Among those who contracted the virus at work, we further examined how many healthcare professionals were eligible for compensation under insurance frameworks related to Long- COVID.

Results: The data analysis reveals that, out of the entire sample examined, 10 healthcare workers developed Long-COVID syndrome, with a severity classified as moderate (Biological Damage according to social insurance of healthcare workers: 1-15%). The lingering ef-fects included persistent asthenia, anosmia, stress-induced dyspnoea, outcomes of instrumentally documented pneumonia and myocarditis, as well as neuromuscular disorders. The collected data confirms that healthcare professionals had the highest percentage of COVID-19 infections (Fig. 1), with an infection rate of 23%, more than half of which occurred in the workplace.

Discussion and conclusions: The definition of long-COVID is still quite complicated, as the ever-increasing number of symptoms that are attributable to this pathology, and the variability in the times of its onset, make its nosographic framework extremely difficult. In addition to the clinical-scientific difficulties arising from this condition, the impossibility of adequately classifying the pathology is associated with an equally complex management of the costs that the State must bear to restore the damage, as it usually happens in case of sequelae of infections contracted at workplace.

某大学医院医护人员长期慢性阻塞性肺病的发生以及保险和赔偿评估方面的挑战。
导言:2019 年发展起来的严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)导致了 COVID-19 大流行状态的爆发,对全世界的医疗系统产生了重大影响。在大流行期间,除了与疾病活动期的高死亡率和高发病率有关的所有问题外,还必须应对一种被称为 "Long-COVID "的病症。长期 COVID 包括症状和体征持续 4 至 12 周的持续症状型和症状持续 12 周以上的后 COVID 综合征。评估系统根据生物有效性受损程度将 COVID-19 结果分为四个等级:轻度、中度、中重度和重度。在保险领域,这一新的 "实体 "导致了与工作场所感染损害赔偿有关的困难,至今仍未完全澄清:这项研究以墨西拿 "G. Martino "大学医院的 3127 名医护人员为样本。研究分析了感染COVID-19的人员比例,评估了有多少人是在工作场所感染的。在那些在工作场所感染病毒的人中,我们进一步研究了有多少医护人员有资格在与长COVID相关的保险框架下获得赔偿:数据分析显示,在所有受检样本中,有 10 名医护人员患上了 Long-COVID 综合征,其严重程度被归类为中度(根据医护人员的社会保险,生物损伤为 1-15%):1-15%).挥之不去的影响包括持续性气喘、嗅觉障碍、压力引起的呼吸困难、仪器记录的肺炎和心肌炎结果以及神经肌肉障碍。收集到的数据证实,医护人员感染 COVID-19 的比例最高(图 1),感染率为 23%,其中一半以上发生在工作场所:长期 COVID 的定义仍然相当复杂,因为可归因于这种病症的症状越来越多,而且发病时间也不尽相同,这使其命名框架变得极为困难。除了这种病症带来的临床科学困难之外,无法对这种病症进行适当分类还与国家为恢复损害而必须承担的费用的管理同样复杂有关,这通常发生在工作场所感染后遗症的情况下。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinica Terapeutica
Clinica Terapeutica PHARMACOLOGY & PHARMACY-
CiteScore
2.50
自引率
0.00%
发文量
124
审稿时长
6-12 weeks
期刊介绍: La Clinica Terapeutica è una rivista di Clinica e Terapia in Medicina e Chirurgia, fondata nel 1951 dal Prof. Mariano Messini (1901-1980), Direttore dell''Istituto di Idrologia Medica dell''Università di Roma “La Sapienza”. La rivista è pubblicata come “periodico bimestrale” dalla Società Editrice Universo, casa editrice fondata nel 1945 dal Comm. Luigi Pellino. La Clinica Terapeutica è indicizzata su MEDLINE, INDEX MEDICUS, EMBASE/Excerpta Medica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信